Jefferies Financial Group’s Xenon Pharmaceuticals XENE Stock Holding History

Jefferies Financial Group’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,200	Closed	-$992K	–	1898
2024 Q3	$992K	Hold	25,200	–	–	0.01%	791
2024 Q2	$983K	Hold	25,200	–	–	0.01%	752
2024 Q1	$1.08M	Sell	25,200 -17,300	-41%	-$796K	0.01%	793
2023 Q4	$1.96M	Buy	42,500 +14,200	+50%	+$502K	0.01%	721
2023 Q3	$967K	Hold	28,300	–	–	0.01%	846
2023 Q2	$1.09M	Buy	28,300 +11,900	+73%	+$473K	0.01%	876
2023 Q1	$587K	Hold	16,400	–	–	﹤0.01%	1050
2022 Q4	$647K	Buy	+16,400	New	+$597K	﹤0.01%	984

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jefferies Financial Group's XENE Position: Q4 2024 in Review

Jefferies Financial Group sold out of Xenon Pharmaceuticals (XENE) in Q4 2024, closing a stake of 66,500 shares — an estimated $2.62M sold.

Jefferies Financial Group first reported a position in XENE in Q4 2022 and held it in 7 quarters. The position peaked at $3.07M in Q4 2023. 209 funds tracked by Wall St. Rank hold XENE as of Q4 2024.

Jefferies Financial Group reported no remaining Xenon Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Jefferies Financial Group sold 66,500 Xenon Pharmaceuticals shares in Q4 2024, an estimated $2.62M.
Jefferies Financial Group first reported a position in Xenon Pharmaceuticals in Q4 2022 and held it in 7 quarters.
Jefferies Financial Group's Xenon Pharmaceuticals position peaked at $3.07M in Q4 2023.
209 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2024.

Based on Jefferies Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.